Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-017559

EVP and General Counsel sold 3,970 shares at $138.17 ($548,535)

  • EVP and General Counsel acquired 10,136 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Parschauer Karah Herdman · EVP and General Counsel

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-01 Grant or award : show line 1 in the form +5,500 29,561 D
2021-03-01 Grant or award : show line 2 in the form +4,636 34,197 D
2021-03-01 Sale : show line 3 in the form −3,970 $138.17 $548,535 30,227 D
Open-market sales · 3,970 sh · avg $138.17 · $548,535

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-01 Grant or award : show line 4 in the form Stock Option (Right to Buy) +11,000 11,000 D
Loading xslF345X03/doc4.xml…